Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.27.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.277EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.413EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.268EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.409EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used